抑郁症与蛋白质能量消耗在肾脏病中的系统综述与荟萃分析
该系统综述与荟萃分析纳入34项研究共5652名慢性肾脏病或终末期肾病患者,评估抑郁与炎症生物标志物的关系。结果显示抑郁患者白蛋白较低、CRP和IL-6较高,且白蛋白、高敏CRP和IL-6与抑郁症状严重程度相关。
要点
- 抑郁与低白蛋白、高CRP和高IL-6相关
- 白蛋白、高敏CRP和IL-6与抑郁症状严重度相关
- 抗抑郁治疗对炎症标志物影响的研究不足
核心结论
- 低白蛋白和高IL-6与抑郁的存在及严重程度均相关,CRP与抑郁存在相关,高敏CRP与抑郁症状严重程度相关。
- 在肾脏病合并抑郁患者中降低炎症的干预效果值得研究。
研究设计与样本
- 系统综述与荟萃分析,检索截至2019年3月19日,由2名作者完成。
- 34项研究(5652名参与者)比较抑郁与非抑郁个体的生物标志物。
- 仅6项研究(321名参与者)探讨抗抑郁治疗对炎症生物标志物的影响,不足以合并进行荟萃分析。
主要发现
- 抑郁患者白蛋白水平较低(标准化均数差 -0.37;95%CI -0.61至-0.13)。
- 抑郁患者CRP水平较高(标准化均数差 0.76;95%CI 0.16至1.37)。
- 抑郁患者IL-6水平较高(标准化均数差 0.42;95%CI 0.21至0.63)。
- 抑郁症状严重程度与白蛋白相关(Z = -0.25;95%CI -0.36至-0.14)。
- 抑郁症状严重程度与高敏CRP相关(Z = 0.28;95%CI 0.13至0.43),与IL-6相关(Z = 0.34;95%CI 0.18至0.49)。
临床怎么用
- 在肾脏病合并抑郁患者中可关注白蛋白、CRP、高敏CRP和IL-6等炎症标志物。
- 抑郁症状严重程度可与白蛋白、高敏CRP和IL-6水平相关,提示炎症可能参与抑郁病理。
- 降低炎症的干预措施对肾脏病合并抑郁患者的效应尚需进一步研究。
局限性
- 白蛋白、CRP、高敏CRP和肿瘤坏死因子-α的研究间存在异质性。
- IL-6研究间存在异质性。
- 抗抑郁治疗对炎症生物标志物影响的研究数量少(仅6项,321名参与者),不足以进行荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Depression comorbid with chronic disease may be mediated by inflammation. We sought to characterize relationships between inflammatory biomarkers and depressive symptoms in patients with chronic kidney disease and end-stage kidney disease. METHODS: A systematic literature search was conducted by 2 authors up to March 19, 2019, for studies of patients with chronic kidney disease or end-stage kidney disease evaluating circulating inflammatory biomarkers associated with depression of chronic disease: albumin, C-reactive protein (CRP), high-sensitivity CRP, interleukin-6 (IL-6), tumor necrosis factor-α, and interleukin-1. Standardized mean differences in biomarkers between individuals with and without depression were computed and analyzed using mixed effects models. Correlations between biomarkers and the severity of depressive symptoms were computed. RESULTS: Thirty-four studies (5652 participants) compared biomarkers between depressed and nondepressed individuals. Individuals with depression had lower albumin levels (standardized mean difference, -0.37; 95% confidence interval [CI], -0.61 to -0.13), higher CRP levels (standardized mean difference, 0.76; 95% CI, 0.16-1.37), and higher IL-6 levels (standardized mean difference, 0.42; 95% CI, 0.21-0.63). Studies were heterogeneous for albumin, CRP, high-sensitivity CRP, and tumor necrosis factor-α. Twenty-three studies (3047 participants) investigated correlations between biomarkers and depressive symptoms. The severity of depressive symptoms correlated with albumin (Z = -0.25; 95% CI, -0.36 to -0.14), high-sensitivity CRP (Z = 0.28; 95% CI, 0.13-0.43), and IL-6 (Z = 0.34; 95% CI, 0.18-0.49). There was heterogeneity across studies of IL-6. Only 6 studies (321 participants) investigated the effect of antidepressant treatment on inflammatory biomarkers, which was insufficient to combine in meta-analysis. CONCLUSION: Lower albumin and higher IL-6 were associated with both the presence and severity of depression, CRP with the presence of depression, and high-sensitivity CRP with the severity of depressive symptoms. The effect of interventions to lower inflammation in patients with kidney disease and depression deserves investigation.
引用
- Gregg LP, Carmody T, Le D, et al. A Systematic Review and Meta-Analysis of Depression and Protein-Energy Wasting in Kidney Disease. Kidney Int Rep. 2019. PMID: 32154453. doi:10.1016/j.ekir.2019.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。